Cite
HARVARD Citation
Follo, M. et al. (n.d.). Molecular Characterization of High-Risk MDS Patients Treated with Azacitidine and Lenalidomide: Role of Inositide-Dependent Signalling, Mutations and Microrna. Leukemia research. pp. S54-S55. [Online].